First Time Loading...

Hangzhou Tigermed Consulting Co Ltd
SZSE:300347

Watchlist Manager
Hangzhou Tigermed Consulting Co Ltd Logo
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Watchlist
Price: 59.11 CNY -0.94% Market Closed
Updated: May 5, 2024
Section:
 

Relative Value

The Relative Value of one Hangzhou Tigermed Consulting Co Ltd stock under the Base Case scenario is 132.64 CNY. Compared to the current market price of 59.11 CNY, Hangzhou Tigermed Consulting Co Ltd is Undervalued by 55%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
132.64 CNY
Undervaluation 55%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

6
P/S
P/S
Price to Sales
6
vs History
90
vs Industry
31
Median 3Y
10.9
Median 5Y
14.7
Industry
3.9
Forward
4.9
More Details
21.9
P/E
P/E
Price to Earnings
21.9
vs History
82
vs Industry
30
Median 3Y
26.8
Median 5Y
46.9
Industry
31.1
Forward
20.9
More Details
38.5
P/OCF
P/OCF
Price to OCF
38.5
vs History
85
vs Industry
13
Median 3Y
54.2
Median 5Y
67
Industry
23.3
More Details
29.1
P/FCFE
P/FCFE
Price to FCFE
29.1
vs History
63
vs Industry
22
Median 3Y
31.2
Median 5Y
35.2
Industry
27.4
More Details
2.1
P/B
P/B
Price to Book Value
2.1
vs History
90
vs Industry
51
Median 3Y
3.6
Median 5Y
5.5
Industry
2.5
More Details
5.4
EV/S
EV/S
Enterprise Value to Sales
5.4
vs History
90
vs Industry
32
Median 3Y
9.8
Median 5Y
13.4
Industry
3.8
Forward
4.4
More Details
13.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
13.9
vs History
90
vs Industry
23
Median 3Y
24
Median 5Y
31.3
Industry
7.9
More Details
23.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
23.2
vs History
90
vs Industry
19
Median 3Y
38.2
Median 5Y
60.6
Industry
17.2
Forward
13.5
More Details
23.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
23.2
vs History
90
vs Industry
26
Median 3Y
38.2
Median 5Y
60.6
Industry
22.7
Forward
16.2
More Details
34.5
EV/OCF
EV/OCF
Enterprise Value to OCF
34.5
vs History
85
vs Industry
15
Median 3Y
48.9
Median 5Y
66.9
Industry
21.4
More Details
47.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
47.4
vs History
85
vs Industry
13
Median 3Y
66
Median 5Y
94
Industry
27.9
More Details
1.8
EV/IC
EV/IC
Enterprise Value to IC
1.8
vs History
90
vs Industry
50
Median 3Y
3.6
Median 5Y
7.7
Industry
2.4
More Details

Multiples Across Competitors

Competitors Multiples
Hangzhou Tigermed Consulting Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
44.3B CNY 6 21.9 23.2 23.2
US
Thermo Fisher Scientific Inc
NYSE:TMO
221.3B USD 5.2 36.9 22.8 33.4
US
Danaher Corp
NYSE:DHR
184B USD 4.2 22.8 16.6 20.4
CH
Lonza Group AG
SIX:LONN
37.5B CHF 5.6 57.3 19.7 28.9
US
IQVIA Holdings Inc
NYSE:IQV
40.5B USD 2.7 29.9 16.3 25.2
US
Agilent Technologies Inc
NYSE:A
40.9B USD 6.1 33.1 26.4 31.8
KR
Samsung Biologics Co Ltd
KRX:207940
54.9T KRW 14.9 64 33.7 48.6
US
Mettler-Toledo International Inc
NYSE:MTD
26.9B USD 7.1 34.2 23.9 26.5
US
West Pharmaceutical Services Inc
NYSE:WST
26.6B USD 9.1 46.9 32.5 39.5
IE
ICON PLC
NASDAQ:ICLR
25.6B USD 3.1 37.4 16.9 26
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.2B EUR 7.1 75.4 32.4 53.2

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.